HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].

Abstract
A patient with carcinoid syndrome was treated with the somatostatin analogue (SMS 201-995). The drug significantly improved the symptoms of the patient, flushing and diarrhea, and reduced urinary excretion of 5-hydroxyindole acetic acid. However, hepatic metastases remained unchanged. Clinical or biochemical adverse effects were not present during the treatment period.
AuthorsA Del Val, J Ponce, A Talens, L Martí-Bonmati, V Garrigues, J Berenguer
JournalRevista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (Rev Esp Enferm Dig) Vol. 79 Issue 3 Pg. 215-7 (Mar 1991) ISSN: 1130-0108 [Print] Spain
Vernacular TitleRespuesta favorable al análogo de la somatostatina SMS 201-995 en un paciente con síndrome carcinoide.
PMID2043408 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Octreotide
Topics
  • Adult
  • Drug Evaluation
  • Drug Tolerance
  • Humans
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Malignant Carcinoid Syndrome (diagnosis, drug therapy)
  • Neoplasms, Unknown Primary (drug therapy)
  • Octreotide (adverse effects, therapeutic use)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: